[ Price : $8.95]
FDA says it is reprioritizing planned inspections for the rest of the year due to challenges it faces after 170 administrative and...[ Price : $8.95]
FDA clears a Medivis 510(k) for its Spine Navigation platform that uses augmented reality and artificial intelligence (AI) to assi...[ Price : $8.95]
HHS begins terminating FDA employees, with many receiving email notifications in the early morning hours or being denied entrance ...[ Price : $8.95]
FDA accepts for priority review an Apellis Pharmaceuticals supplemental NDA for Empaveli (pegcetacoplan) for treating two severe a...[ Price : $8.95]
Despite HHS secretary Robert F. Kennedy, Jr.s promises to boost transparency at HHS and its health agencies, staff cuts now occurr...[ Price : $8.95]
FDA warns Columbus, OH-based Rex Implants that it is illegally manufacturing and distributing three medical devices.[ Price : $8.95]
Bausch + Lomb recalls all enVista intraocular lenses due to increasing adverse event reports of toxic anterior segment syndrome as...[ Price : $8.95]
Axsome Therapeutics says its solriamfetol missed the primary endpoint in a Phase 3 proof-of-concept trial to treat major depressiv...